Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Sold are for 40k Tests. Quotes for 280k tests.
Bigger question about the sales mentioned tests or kits? If it’s 140,000 kits that’s phenomenal income
RNS 06.12.2018 - Completion of q16 molecular diagnostics order.
This was 100 q16 Primerdesign instruments sent to China, suitable for testing with the new CE labelled test kit.
I have seen no feedback on their use in any articles I have read.
Perhaps some have been disassembled for cloning
Hong Kong (CNN)Public health officials warned Wednesday that the spread of the novel coronavirus is inching closer toward meeting the definition of a global pandemic, as the number of cases outside mainland China continues to grow, including in South Korea where a US soldier has tested positive for the virus.
Iran and Italy are also grappling with major outbreaks within their borders that have turned deadly, and a top official from the US Centers for Disease Control and Prevention (CDC) warned that the United States could see the virus spread within its borders.
"Ultimately we expect we will see community spread in this country. It's not so much a question of if this will happen anymore, but rather more a question of exactly when this will happen and how many people in this country will have severe illness," said Dr. Nancy Messonnier, the director of the CDC's National Center for Immunization and Respiratory Diseases.
South Korea currently has the largest outbreak outside mainland China, with more than 1,100 people infected -- including the first US soldier -- and at least 12 dead. Iran's health ministry has confirmed at least 95 cases and 15 fatalities. In Italy, at least 322 people have been infected and 11 have been killed, while Algeria, Croatia, mainland Spain and Switzerland all announced their first confirmed cases.
The World Health Organization (WHO) has so far held off on classifying the coronavirus' spread as a global pandemic, but the outbreak appears to be getting closer to meeting the global health body's definition of one.
It's going to be a blue day and the derampers know it too.
Novacyt requires cash with order, so if orders are increasing, so is profits.
Lets be having that RNS please..
Yes. China are already using tests from at least 3 that we know of Chinese companies. Novacyt need to get in on those sales to make a difference
They said they had a 50% conversion rate, quotes to orders.
With the panic to get testing equipment in place, I would imagine the conversion rate is much higher now.
We have had no RNS to reflect what the new levels of interest are, and I suspect the Novocyt / Primerdesign management are in lengthy discussions with health officials of many countries, so no time to compile an RNS.
Rules are rules, and if orders are increasing, then share holders should be informed.
However another reason for no news may be because there is a takeover/jv/merger to be announced.
JM2c
Midas - the next RNS needs to have US or Chinese FDA approval attached to it aswell. If they just come back with sales figures and they are anything other than spectacular. I think we know what will happen.
They said they have a conversion rate of around 50%. They need to have sold a lot more since that quote. The company has increased in value by £80million on the back of this. They need to publish figures way in excess of what they have quoted so far
You would think there would be an update. 1st Feb to 7th Feb 33k tests sold. 7th Feb - 17th Feb 7k more sold to give a total of 40k tests sold - around £200k worth. They said they have a high conversion rate from quotes to sales. The next sales figures need to be in the Millions to sustain this share price.